The Neuroscience Center

  • Home
    • The Neuroscience Center Story
    • Evaluation and Treatment
    • Expertise and Special Interest
  • About Us
    • Steve Best, M.D.
    • Dan G. Pavel, MD
    • John Hughes M.D. Ph.D
    • Petronilo Costa, MD
    • Dr. Michael Easton, MD (Consultant)
    • Brenden Cochran, ND
    • Cindy McKinzie, PsyD, RYT
    • Melanie E. Dillon, MA, LCPC
    • Kyle S. Ferroly, Ph.D
    • John C. LeMay, QEEG-D, MFT, BCB
    • Press
  • What We Do
  • Services
    • Brain SPECT Imaging
    • Hyperbaric Oxygen Therapy
    • TMS/ketamine
    • Ketamine Assisted Psychotherapy (KAP)
    • Dementia Care and Cognitive Impairment Clinic
    • SPRAVATO™ Clinic
    • Correcting Inborn Errors of Metabolism
    • Nutrition Based Intervention
    • Cannabis and CBD Related Services
  • Education
    • Pain
    • Mood
    • Head Injury
    • Stroke
    • Cognitive Impairment
    • Development
    • Substance Abuse
    • Additional Topics
  • Contact
    • Schedule Appointment
    • Patient Information
      • Policy
      • Patient FAQ – Frequently Asked Questions
      • CPT Billing Codes
    • Directions
  • Partners
    • Hyperbaric Centers of Chicago
    • PathFinder Brain SPECT Imaging
    • Entourage Clinical Services
  • Library
    • Patient Resources
    • Provider Resources
    • Blog
You are here: Home / A very potent route into the mind (olfaction)

Olfaction is a vital component in early bonding of child with parent, and allows us be “oriented in our surroundings”, and a source of great aesthetic pleasure. Olfaction can be lost by certain kinds of physical trauma, and often by degenerative brain disease. In addition, parental olfaction can influence behavior in subsequent generations – apparently through epigenetic mechanisms.

Olfaction is impaired in illnesses that occur in the developmental years: attention deficit/hyperactivity disorder (ADHD), as well as autism spectrum disorders (ASDs), schizophrenia, and obsessive compulsive disorder (OCD).

Olfaction can become less intense in our later years, but is also less intense during the developmental years. In 2014 Doty reported: “Decreased olfactory function is very common in the older population, being present in over half of those between the ages of 65 and 80 years and in over three quarters of those over the age of 80 years. Such dysfunction significantly influences physical well-being and quality of life, nutrition, the enjoyment of food, as well as everyday safety. Indeed a disproportionate number of the elderly die in accident gas poisonings each year.”

Olfaction can also become impaired in multiple sclerosis (MS), Parkinson’s disease, and Alzheimer’s Disease.

There is little treatment available. In 2013 Moon reported on a relatively small study of 40 patients: “In conclusion, Stellate Ganglion Block (SGB) is a simple, safe, long-lasting, and effective therapeutic modality for olfactory dysfunction patients, such as those with anosmia and hyposmia.”

Copyright © 2021 · The Neuroscience Center · All Rights Reserved · Terms of Use

440 Lake Cook Road, Building 2, Deerfield, IL 60015 · Office (847) 236-9310

Facebook